A new treatment for coronary and peripheral artery disease is superior to corresponding conventional treatments. Two IN.PACT drug-eluting balloons, produced by Medtronic, Inc., were tested in multicenter, randomized controlled trials. In one study, the safety and effectiveness of the IN.PACT Falcon was evaluated in comparison with the Taxus drug-eluting stent (DES) from Boston Scientific Corp. in reducing late lumen loss (the change in the diameter of a stent after it is first placed) in...
↧
